Starpharma Holdings Limited (SPHRF)
OTCMKTS
· Delayed Price · Currency is USD
0.0675
+0.0078 (13.07%)
At close: Jun 2, 2025
Starpharma Holdings Revenue
Starpharma Holdings had revenue of 2.43M AUD in the half year ending December 31, 2024, with 41.85% growth. This brings the company's revenue in the last twelve months to 4.16M, down -60.98% year-over-year. In the fiscal year ending June 30, 2024, Starpharma Holdings had annual revenue of 9.76M with 124.64% growth.
Revenue (ttm)
4.16M AUD
Revenue Growth
-60.98%
P/S Ratio
9.69
Revenue / Employee
103.95K AUD
Employees
40
Market Cap
24.93M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 9.76M | 5.41M | 124.64% |
Jun 30, 2023 | 4.34M | -819.00K | -15.87% |
Jun 30, 2022 | 5.16M | 1.68M | 48.04% |
Jun 30, 2021 | 3.49M | -3.63M | -50.99% |
Jun 30, 2020 | 7.12M | 4.40M | 161.58% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 84.04M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |